Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Amaryl
Generic name / active ingredient
glimepiride
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check AMARYL, glimepiride, 1/2/4 mg, NDC, the 100-tablet bottle and market together. mg is a labelled amount per tablet in this historical label, not a web rule for tablets per day, adding strengths or replacing another glucose-lowering medicine.
  • This historical label describes two score marks on all three tablets. Score marks and color are pack/tablet checking clues, not instructions to self-split, change use, combine products or substitute another strength; the historical label also cannot be extended to a generic tablet, another market or a current product.
  • The label warns about hypoglycemia, serious hypersensitivity, hemolytic anemia related to G6PD deficiency and multiple interactions; older people, people with renal impairment or people using another glucose-lowering medicine especially need review by a professional who knows the complete history and medicine list. This page does not decide continuation, pausing, make-up use or a treatment change for anyone.
  • For suspected hypoglycemia, altered consciousness, seizure, serious allergic features or another acute serious concern, use local urgent and medical pathways; do not self-treat with sugar, make up medicine, stop or adjust based on this page.

Reviewed presentation examples — compare every field

  • Glimepiride 1 mg per tablet; 100-tablet bottle (historical U.S. label)NDC 0039-0221-10
  • Glimepiride 2 mg per tablet; 100-tablet bottle (historical U.S. label)NDC 0039-0222-10
  • Glimepiride 4 mg per tablet; 100-tablet bottle (historical U.S. label)NDC 0039-0223-10

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image